Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDER Director Sees Behind-The-Counter Switches As Best Bet

This article was originally published in The Tan Sheet

Executive Summary

FDA drug center chief Janet Woodcock says behind-the-counter switches would be the most effective method to make Rx drugs available without prescriptions, particularly to help treat chronic conditions.
Advertisement

Related Content

OTC Switch “Blueprint” Could Help Regulatory Navigation – Researchers
Asthma Treatment OTC Switches Would Face Tough Barriers
FDA Expects OTC Switch Self-Selection Studies To Probe Consumer Thinking
Lipitor OTC Switch Would Force Pfizer To Clear Big Research Hurdles
Pfizer Consumer Chief Sees Chronic Conditions In OTC Future
The Future Of OTCs: Self-Selection Meets Diagnostics, Genetic Personalization
Global Switches Might Be Easier As Governments Seek To Cut Expenditures
CDER Director Sees Behind-The-Counter Switches As Best Bet
Behind-The-Counter Guidance Stalled, But Interest Grows To Expand Access
Behind-The-Counter Guidance Stalled, But Interest Grows To Expand Access

Topics

Advertisement
UsernamePublicRestriction

Register

PS104973

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel